10 小时on MSN
NeurAxis outlines commercial readiness for 2026 as double-digit growth continues and CPT ...
Discover key insights from NeurAxis' Q3 2025 earnings call—revenue growth, commercialization strategy, and outlook ahead of the new CPT code in 2026.
Widely-used billing codes have been updated for 2024, including new ones for respiratory syncytial virus (RSV) vaccines and medications, and new Spanish translations. The American Medical Association ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果